ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01769547
Brief Title: A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy (DOVE-M)

First Submitted : January 9, 2013
First Submitted that Met QC Criteria : January 15, 2013
First Posted : January 16, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : September 16, 2015
Last Update Posted : September 17, 2015 (Estimate)